iHIS Rebrands to Synapxe and Debuts the New AI Healthcare Solutions
References: synapxe.sg & healthcareitnews
Synapxe, formerly known as Integrated Health Information Systems, has undergone a significant rebranding effort to improve its services as Singapore's national health tech agency. With this transformation, the brand has redefined its mission, emphasizing the acceleration of the advancement and implementation of cutting-edge health technologies, including artificial intelligence.
Synapxe is introducing a series of new AI-powered health solutions to achieve this goal. Among these groundbreaking innovations is the ACE-AI (Assisted Chronic Disease Explanation using AI), a unique tool that employs artificial intelligence to identify potential risk factors and automate risk calculations, enabling the early detection of chronic diseases.
The company has also previewed its AIM.SG platform, which was developed in collaboration with SingHealth and NTT Data. This revolutionary technology empowers rapid AI imaging model development, testing, and deployment to benefit healthcare agencies.
Image Credit: Synapxe
Synapxe is introducing a series of new AI-powered health solutions to achieve this goal. Among these groundbreaking innovations is the ACE-AI (Assisted Chronic Disease Explanation using AI), a unique tool that employs artificial intelligence to identify potential risk factors and automate risk calculations, enabling the early detection of chronic diseases.
The company has also previewed its AIM.SG platform, which was developed in collaboration with SingHealth and NTT Data. This revolutionary technology empowers rapid AI imaging model development, testing, and deployment to benefit healthcare agencies.
Image Credit: Synapxe
Trend Themes
1. AI-powered Health Solutions - Synapxe is introducing a series of new AI-powered health solutions, including ACE-AI, a tool that enables early detection of chronic diseases.
2. Health Tech Rebranding - Synapxe's rebranding effort aims to improve its services as Singapore's national health tech agency and accelerate the implementation of cutting-edge health technologies.
3. Revolutionary AI Imaging Platform - Synapxe has previewed AIM.SG, a revolutionary technology developed in collaboration with SingHealth and NTT Data, empowering rapid AI imaging model development for healthcare agencies.
Industry Implications
1. Healthcare Technology - Synapxe's AI-powered health solutions have the potential to disrupt the healthcare technology industry with tools like ACE-AI that enable early detection of chronic diseases.
2. Healthcare Agencies - The development of AIM.SG by Synapxe in collaboration with SingHealth and NTT Data could revolutionize how healthcare agencies develop, test, and deploy AI imaging models.
3. National Health Tech - Synapxe's rebranding as Singapore's national health tech agency positions them to lead the acceleration of cutting-edge health technologies, including AI-powered solutions.
5.3
Score
Popularity
Activity
Freshness
